Introduction Sickle cell disease (SCD) is a genetic disorder that disproportionally affects people of African descent ( Intravascular hemolysis, a critical contributor to vaso-occlusive crises---the principal pathological manifestation of SCD---refers to the destruction of red blood cells (RBCs) within the blood vessels (Van Avondt et al., 2019)
(You can search the NIHR 'Be Part of Research' website, but always discuss eligibility with your clinician) What are the established treatment options that might better address my symptoms
If your provider plans to increase beyond 10mg, this is typically when they switch you to a 20mg/ml vial
377(2):153159 Gastric pentadecapeptide body protection compound BPC 157 and its role in musculoskeletal tissue models Bock-Marquette I, Maar K, Maar S, Lippai B, Faskerti G, Gallyas F Jr, Olson EN, Srivastava D., International Immunopharmacology , 2023